Ignite Creation Date:
2024-05-06 @ 7:33 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06059885
Status:
RECRUITING
Last Update Posted:
2023-09-29
First Post:
2023-09-14
Brief Title:
Tislelizumab Plus TKI as Adjuvant Therapy Versus Active Surveillance in Patients With HCC
Sponsor:
Organization:
Beijing 302 Hospital